Clinical Database and Biobank of Patients With Gynecologic Neoplasms
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The database and biobank establishment started in 1997 in our institute. However, the sample size was too small with respect to our clinical and fundamental scientific research's requirement. Thus the Chinese gynecological oncology study (GOS) group was established to create a large multicentre database and biobank of patients with gynecologic diseases.
| Condition |
|---|
|
Cervical Cancer Ovarian Cancer Endometrial Cancer Choriocarcinoma Uterine Fibroids Endometriosis |
| Study Type: | Observational |
| Official Title: | A Large Multicentre Clinical Database and Biobank of Patients With Gynecologic Neoplasms |
| Study Start Date: | January 1999 |
The database contains clinical and epidemiologic information about patients with gynecologic neoplasms, such as cervical carcinoma, ovarian carcinoma, etc. With the data gathered from this database, the investigators could further demonstrate the etiology, risk factor, clinical treatment, and other aspects of the complicated gynecologic diseases. The cervical cancer database v1.10 including more than 10,000 cases and more than 200 variables has been established.
The biobank collects blood, fluids, tissue samples, and related clinical data from consenting patients with gynecologic neoplasms, such as cervical cancer, ovarian cancer, endometrial cancer, choriocarcinoma, uterine myoma, endometriosis. Besides, blood samples of population-based healthy people with informed consent are also collected.
Eligibility| Ages Eligible for Study: | 18 Years to 75 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Probability Sample |
gynecologic diseases, such as cervical cancer, ovarian cancer, endometrial cancer, choriocarcinoma, uterine myoma, endometriosis, as well as part of population-based healthy women
Inclusion Criteria:
- patients with informed consent;
- patients with gynecologic diseases;
- patients with intact clinical and pathological information
Exclusion Criteria:
- not included in the inclusion criteria
Contacts and Locations| Contact: Ma Ding, M.D. | 86-27-8362681 | dma@tjh.tjmu.edu.cn |
| China, Hubei | |
| Tongji Hospital of HUST | Recruiting |
| Wuhan, Hubei, China | |
| Contact: Ma Ding, M.D. 86-27-8362681 dma@tjh.tjmu.edu.cn | |
More Information
No publications provided by Huazhong University of Science and Technology
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Ding Ma, Cancer Biology Research Center of Tongji Hospital |
| ClinicalTrials.gov Identifier: | NCT01267851 History of Changes |
| Other Study ID Numbers: | GM2010-06-02 |
| Study First Received: | December 28, 2010 |
| Last Updated: | February 14, 2011 |
| Health Authority: | China: Ministry of Health |
Keywords provided by Huazhong University of Science and Technology:
|
gynecologic disease |
Additional relevant MeSH terms:
|
Genital Diseases, Female Neoplasms Endometrial Neoplasms Uterine Cervical Neoplasms Choriocarcinoma Endometriosis Genital Neoplasms, Female Leiomyoma Ovarian Neoplasms Myofibroma Adenoma Uterine Neoplasms Urogenital Neoplasms Neoplasms by Site Uterine Diseases |
Uterine Cervical Diseases Trophoblastic Neoplasms Neoplasms, Germ Cell and Embryonal Neoplasms by Histologic Type Gestational Trophoblastic Neoplasms Adenocarcinoma Carcinoma Neoplasms, Glandular and Epithelial Pregnancy Complications, Neoplastic Pregnancy Complications Neoplasms, Muscle Tissue Neoplasms, Connective and Soft Tissue Endocrine Gland Neoplasms Ovarian Diseases Adnexal Diseases |
ClinicalTrials.gov processed this record on May 16, 2013